Yep - you are correct re the 6 week stabilisation and that many are screened out of the trial which delays the process - but not for nearly as long as you were suggesting in your previous post.
Based on the 24 Jul 23 announcement, 133 had been recruited and 72 had been randomised. It is not clear whether all the 133 were screened for the purpose of finalising the first 72 cohort but if they were, that is a 55% strike rate.
That implies - if that rate continues but will probably now speed up with China on board - a 13 month recruitment window for the 2nd cohort from Jul 2023. That takes it to Aug 2024 for 72 randomised. Then 35 weeks dosing takes it to May 2025 and the possibility of accelerated marketing approval.
- Forums
- ASX - By Stock
- DXB
- Ann: ACTION3 IND Approved in China
Ann: ACTION3 IND Approved in China, page-101
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 37.0¢ | $503.5K | 1.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26318 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 170072 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1318 | 0.380 |
3 | 72579 | 0.375 |
4 | 134161 | 0.370 |
1 | 30000 | 0.365 |
4 | 27499 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 140963 | 5 |
0.395 | 61740 | 2 |
0.400 | 115000 | 2 |
0.405 | 86528 | 4 |
0.410 | 56400 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |